The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: rituximab     Quarter: 2016Q3

Total Records: 1,104     Number of Pages: 56

DRUGNAME PT EventCount
Rituximab Peripheral sensorimotor neuropathy 2
Rituximab Peripheral sensory neuropathy 2
rituximab Plasma cell myeloma 2
Rituximab Polyomavirus-associated nephropathy 2
Rituximab Postoperative wound infection 2
rituximab Primary mediastinal large B-cell lymphoma 2
Rituximab Product taste abnormal 2
Rituximab Pseudomonal sepsis 2
Rituximab Pubis fracture 2
RITUXIMAB Pulmonary thrombosis 2
Rituximab Pulseless electrical activity 2
Rituximab Rash papular 2
RITUXIMAB Renal cell carcinoma 2
Rituximab Renal disorder 2
Rituximab Renal neoplasm 2
Rituximab Retinal detachment 2
Rituximab Retinal haemorrhage 2
Rituximab Rheumatoid nodule 2
RITUXIMAB Rhinovirus infection 2
Rituximab Second primary malignancy 2

Total Records: 1,104     Number of Pages: 56